Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Dermatology
•
Drug Eruptions
After corticosteroids, what second line agent do you select to treat drug induced hypersensitivity syndrome (also known as DRESS syndrome)?
Answer from: at Community Practice
see reference
Sign in or Register to read more
24555
Related Questions
How do you approach monitoring in DRESS or DiHS patients?
In difficult cases, what is your approach to find a causative agent of fixed drug or fixed food eruption?
How do you dose oral tranexamic acid for melasma?
What circumstances would drive you to consider using an oral IL-23 inhibitor over parenteral options for the management of psoriasis and/or psoriatic arthritis?
Does the presence of psoriatic arthritis affect your decision to use an anti-IL-17 or IL-23 drug in your psoriasis patients?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
What treatments can be combined for the treatment of immune checkpoint inhibitor induced toxic epidermal necrolysis?
Are you comfortable utilizing Stelara (ustekinumab) as biologic treatment of psoriasis for patients with a history of severe latex allergy?
Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?
Do you wait on initiating biologic therapy for guttate psoriasis?